Allogene Therapeutics
ALLO
ALLO
191 hedge funds and large institutions have $1.15B invested in Allogene Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
3.71% more ownership
Funds ownership: 70.19% → 73.9% (+3.7%)
0% less capital invested
Capital invested by funds: $1.15B → $1.15B (-$1.81M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
191
Holding in Top 10
2
Calls
$1.99M
Puts
$1.67M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$10.6M | |
| 3 | +$8.76M | |
| 4 |
Two Sigma Investments
New York
|
+$7.28M |
| 5 |
Millennium Management
New York
|
+$6.69M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$13.4M | |
| 3 | -$5.86M | |
| 4 |
JP Morgan Chase
New York
|
-$5.8M |
| 5 |
Morgan Stanley
New York
|
-$5.63M |